➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
McKinsey
Medtronic
Baxter
Dow

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Watson Laboratories Inc. - Florida (D. Del. 2012)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in AbbVie Inc. v. Watson Laboratories Inc. - Florida
The small molecule drug covered by the patents cited in this case is ⤷  Try it Free .

Details for AbbVie Inc. v. Watson Laboratories Inc. - Florida (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-03-16 1 is an action for patent infringement of U.S. Patent Nos. 6,080,428 (―the ’428 patent‖), and 6,469,0356,469,035 (―the ’035 patent‖), arising under the patent laws of the United States, Title 35, United States Code…lawsuits in this District involving the ’428 patent and the ’035 patent: Abbott Laboratories & Abbott Respiratory…copy of the ’428 patent is attached hereto as Exhibit A. The claims of the ’428 patent are valid and enforceable…copy of the ’035 patent is attached hereto as Exhibit B. The claims of the ’035 patent are valid and enforceable External link to document
2012-03-16 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,080,428; 6,469,035 B1;. (els… 12 September 2013 1:12-cv-00324 830 Patent None District Court, D. Delaware External link to document
2013-09-12 42 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,080,428; 6,469,035 B1;. (Attachments… 12 September 2013 1:12-cv-00324 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKinsey
Medtronic
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.